View Author
scopus: 36071184600

Zhang, H.X.

(Hong Xiang Zhang)


plaque patient cancer breast cancer children brca 1 brca 2 mutations breast chek 2*1100delc event family mutation adult quartile individual level 2*1100delc study carotid outcome protein follow-up group erasmus mc analysis proteinuria biopsy university department control atherosclerotic hypercellularity iga nephropathy value netherland table lesion cohort disease nephropathy chek 2 hospital plaque opn levels mesangial variant 0.9 function marker opn plaque levels 2.1 endocapillary erasmu pathology atvb.ahajournals.org decline downloaded intervention library frequency osteopontin figure signi ficantly atherosclerotic plaques signi biomarker glomerulosclerosi endarterectomy proteomic endocapillary hypercellularity history score characteristic fication breast cancer risk article r coppo femoral carrier sample fraction genetic




3 Most Recent Publications

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults (Article)
Coppo, R. Troyanov, S. Barratt, J. Berthoux, F. Bonsib, S. Bruijn, J.A. D'Agati, V. D'Amico, G. Emancipator, S. Emma, F. Ferrario, F. Fervenza, F.C. Camilla, R. Florguin, S. Fogo, A.B. Geddes, C.C. Groene, H.J. Haas, M. Herzenberg, A.M. Hill, P.A. Hsu, S.I. Jennette, J.C. Joh, K. Hogg, R.J. Julian, B.A. Kawamura, T. Lai, F.M. Li, L.S. Li, P.K. Liu, Z.H. Mezzano, S. Schena, F.P. Tomino, Y. Walker, P.D. Cattran, D.C. Wang, H. Weening, J.J. Yoshikawa, N. Zhang, H.X. Cook, H.T. Feehally, J. Roberts, I.S.D. Amore, A. Alpers, C.E.
2010-05-01
Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events (Article)
Kleijn, D.P.V. de Moll, F.L. Daemen, M.J. Biessen, E.A.L. Jager, W. de Zhang, H.X. Vries, J.P. de Falk, E. Lim, S.K. Spek, P.J. van der Sze, S.K. Pasterkamp, G. Hellings, W.E. Ozsarlak-Sozer, G. Bruin, P. de Doevendans, P.A. Vink, A. Catanzariti, L.M. Schoneveld, A.H. Algra, A.
2010-03-01
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations (Article)
Meijers-Heijboer, E.J. Snoo, A. de Schutte, M. McGuffog, L. Thompson, D. Easton, D.F. Sodha, N. Seal, S. Barfoot, R. Mangion, J. Chang-Claude, J. Eccles, D. Oldenburg, R. Eeles, R. Evans, D.G. Houlston, R. Murday, V. Narod, S. Peretz, T. Peto, J. Phelan, C. Zhang, H.X. Szabo, C. Hollestelle, A. Devilee, P. Goldgar, D. Futreal, P.A. Nathanson, K.L. Weber, B.L. Rahman, N. Stratton, M.R. Ouweland, A.M.W. van den Klijn, J.G.M. Wasielewski, M. Houben, M. Elstrodt, F. Crepin, E. Veghel-Plandsoen, M. van Duijn, C.M. van Bartels, C.C.M. Meijers, C.
2002-05-01